MM

Manu Mehta

Active Director Director DIN 10367180
DIN 10367180 First appointment Oct 2023 Primary industry Wood
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Manu Mehta

Data last updated:

Manu Mehta is a Director at Metgene Life Sciences Private Limited (since 2023). The company operates in Wood. Metgene Life Sciences Private Limited reported revenue of ₹1.9 Lakh (FY 2024).

DIN 10367180
Primary Designation Director
Industry Wood
First Appointment 23 Oct 2023
Oldest Company Age 3 yrs
Largest company Metgene Life Sciences Private Limited · ₹1.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20232023₹1.9 Lakh (FY 2024)Active

Board colleagues of Manu Mehta

NameDINCompanyDesignation
Anil Mehta10367181Metgene Life Sciences Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Metgene Life Sciences Private Limited
Premium access

Shareholding and investment profile for Manu Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manu Mehta

Manu Mehta currently holds 1 directorship: Metgene Life Sciences Private Limited (Director, since 23 Oct 2023, revenue ₹1.9 Lakh (FY 2024)).

Manu Mehta was first appointed on 23 Oct 2023 as Director at Metgene Life Sciences Private Limited.

The current boards of Manu Mehta's companies include Anil Mehta (Metgene Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available